William A. Carter

3.1k total citations
83 papers, 2.2k citations indexed

About

William A. Carter is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, William A. Carter has authored 83 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Immunology, 25 papers in Molecular Biology and 16 papers in Epidemiology. Recurrent topics in William A. Carter's work include Immune Response and Inflammation (17 papers), interferon and immune responses (16 papers) and Immune Cell Function and Interaction (9 papers). William A. Carter is often cited by papers focused on Immune Response and Inflammation (17 papers), interferon and immune responses (16 papers) and Immune Cell Function and Interaction (9 papers). William A. Carter collaborates with scholars based in United States, Germany and Japan. William A. Carter's co-authors include Julius S. Horoszewicz, David R. Strayer, Eugene Sulkowski, Hilton B. Levy, Mary W. Davey, Erik De Clercq, Ernest C. Borden, Susan S. Leong, Isadore Brodsky and Joyce M. Zarling and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

William A. Carter

80 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William A. Carter United States 28 983 762 392 374 206 83 2.2k
E. J. Field United Kingdom 31 758 0.8× 1.0k 1.3× 398 1.0× 210 0.6× 197 1.0× 208 3.2k
Michel Séman France 32 1.3k 1.3× 1.4k 1.8× 397 1.0× 633 1.7× 496 2.4× 109 3.9k
Shlomo Ben‐Efraim Israel 21 929 0.9× 630 0.8× 226 0.6× 241 0.6× 257 1.2× 135 2.0k
Milton W. Taylor United States 29 1.2k 1.2× 1.3k 1.7× 709 1.8× 479 1.3× 106 0.5× 94 3.8k
K S Prickett United States 24 900 0.9× 1.6k 2.0× 135 0.3× 344 0.9× 412 2.0× 29 3.0k
Sasha Gupta United States 22 837 0.9× 737 1.0× 298 0.8× 310 0.8× 222 1.1× 34 2.0k
J L Pace United States 26 1.9k 1.9× 797 1.0× 280 0.7× 557 1.5× 175 0.8× 55 3.2k
Achal Pashine United States 20 1.7k 1.7× 623 0.8× 283 0.7× 290 0.8× 192 0.9× 27 2.7k
Hugh F. Pross Canada 26 2.8k 2.8× 646 0.8× 274 0.7× 796 2.1× 399 1.9× 70 3.8k
Francisco Leyva‐Cobián Spain 27 613 0.6× 409 0.5× 346 0.9× 148 0.4× 81 0.4× 66 2.0k

Countries citing papers authored by William A. Carter

Since Specialization
Citations

This map shows the geographic impact of William A. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William A. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William A. Carter more than expected).

Fields of papers citing papers by William A. Carter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William A. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William A. Carter. The network helps show where William A. Carter may publish in the future.

Co-authorship network of co-authors of William A. Carter

This figure shows the co-authorship network connecting the top 25 collaborators of William A. Carter. A scholar is included among the top collaborators of William A. Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William A. Carter. William A. Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Overton, Edgar T., Paul A. Goepfert, William A. Carter, et al.. (2014). Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans. Vaccine. 32(42). 5490–5495. 47 indexed citations
2.
3.
Mitchell, William M., Christopher F. Nicodemus, William A. Carter, Joseph Horváth, & David R. Strayer. (2014). Discordant Biological and Toxicological Species Responses to TLR3 Activation. American Journal Of Pathology. 184(4). 1062–1072. 22 indexed citations
4.
Liu, Qinfang, Jingjiao Ma, David R. Strayer, et al.. (2013). Emergence of a novel drug resistant H7N9 influenza virus: evidence based clinical potential of a natural IFN-α for infection control and treatment. Expert Review of Anti-infective Therapy. 12(2). 165–169. 15 indexed citations
5.
Strayer, David R., William A. Carter, Bruce C. Stouch, et al.. (2012). A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome. PLoS ONE. 7(3). e31334–e31334. 63 indexed citations
6.
Strayer, David R. & William A. Carter. (2011). Recombinant and Natural Human Interferons: Analysis of the Incidence and Clinical Impact of Neutralizing Antibodies. Journal of Interferon & Cytokine Research. 32(3). 95–102. 9 indexed citations
7.
Ichinohe, Takeshi, Akira Ainai, Yasushi Ami, et al.. (2010). Intranasal administration of adjuvant‐combined vaccine protects monkeys from challenge with the highly pathogenic influenza A H5N1 virus. Journal of Medical Virology. 82(10). 1754–1761. 39 indexed citations
8.
Ichinohe, Takeshi, Shinichi Tamura, Akira Kawaguchi, et al.. (2007). Cross‐Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine. The Journal of Infectious Diseases. 196(9). 1313–1320. 107 indexed citations
9.
Carter, William A., Robert J. Suhadolnik, Wernér E.G. Müller, et al.. (1993). Specific RNA Drug Therapy of Hepatitis Viruses. Annals of the New York Academy of Sciences. 685(1). 758–761. 2 indexed citations
10.
Hubbell, Howard R., Hugo E. Vargas, Edward Pequignot, et al.. (1992). Antitumor effects of interleukin-2 and mismatched double-stranded RNA, individually and in combination, against a human malignant melanoma xenograft. Cancer Immunology Immunotherapy. 35(3). 151–157. 4 indexed citations
11.
Strayer, David R., et al.. (1986). Antiproliferative Effect of Mismatched Double-Stranded RNA on Fresh Human Tumor Cells Analyzed in a Clonogenic Assay. Journal of Interferon Research. 6(4). 373–379. 10 indexed citations
12.
Strayer, David R., et al.. (1984). Antiproliferative Effect of Natural Beta Interferon on Fresh Tumor Cells Analyzed in a Clonogenic Assay. Journal of Interferon Research. 4(4). 627–633. 5 indexed citations
13.
Carter, William A.. (1981). [81] Binding of human interferons to immobilized albumin. Methods in enzymology on CD-ROM/Methods in enzymology. 78(Pt A). 576–582. 4 indexed citations
14.
Carter, William A., et al.. (1979). Porcine Leukocyte Interferon and Antiviral Activity in Human Cells. Molecular Pharmacology. 15(3). 685–690. 15 indexed citations
15.
Zarling, Joyce M., Linda Eskra, Ernest C. Borden, Julius S. Horoszewicz, & William A. Carter. (1979). Activation of Human Natural Killer Cells Cytotoxic for Human Leukemia Cells by Purified Interferon. The Journal of Immunology. 123(1). 63–70. 130 indexed citations
16.
Zarling, Joyce M., Jeffrey A. Sosman, Linda Eskra, et al.. (1978). Enhancement of T Cell Cytotoxic Responses by Purified Human Fibroblast Interferon. The Journal of Immunology. 121(5). 2002–2004. 59 indexed citations
17.
18.
Carter, William A.. (1967). Amphibians and Reptiles Known from Pontotoc County, Oklahoma. Proceedings of the Oklahoma Academy of Science. 47. 66–71. 1 indexed citations
19.
Carter, William A.. (1967). Ecology of the Nesting Birds of the McCurtain Game Preserve, Oklahoma. Biodiversity Heritage Library (Smithsonian Institution). 3 indexed citations
20.
Carter, William A.. (1966). Distribution Records for Oklahoma Reptiles. Proceedings of the Oklahoma Academy of Science. 46. 33–36. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. J. Field Breakdown of academic impact, for papers by Michel Séman Breakdown of academic impact, for papers by Shlomo Ben‐Efraim Breakdown of academic impact, for papers by Milton W. Taylor Breakdown of academic impact, for papers by K S Prickett Breakdown of academic impact, for papers by Sasha Gupta Breakdown of academic impact, for papers by J L Pace Breakdown of academic impact, for papers by Achal Pashine Breakdown of academic impact, for papers by Hugh F. Pross Breakdown of academic impact, for papers by Francisco Leyva‐Cobián
Rankless by CCL
2026